same period of last year and an increase of 24.9% over the last quarter . Such increase was mainly due to the increase in aluminium price and the expansion of sales volume from exporting to overseas
the same period of last year and an increase of 1.71% over the last quarter . Such increase was mainly due to the increase in aluminium price and the expansion of sales volume from exporting to overseas
expansion oversea market. The cost of sales decreased 5%., while gross margin rate 11% in the year 2017, 4% in the year 2016. As the result of the company’s gross margin increased 7% compared with the last
% with the increasing from domestic selling price and expansion oversea market. There are gross margin rate or the year 2019 is 19% and 15% in the year 2018. As the result of the company’s gross margin
% with the increasing from domestic selling price and expansion oversea market. There are gross margin rate or the year 2018 is 15% and 10% in the year 2017. As the result of the company’s gross margin
( present value) , financial position, operating results, nature of business operations, potential and opportunity for business expansion and price appraisal by financial advisor. บริษัท ดีโอดี ไบโอเทค จ ำกัด
into account various factors, such as, value of assets ( present value) , financial position, operating results, nature of business operations, potential and opportunity for business expansion and price
operating cost by adding value to their products and expanding selling channels instead. With anticipate the Thai economy to grow by 3.8 percent in 2017, revised upward from the previous forecast and higher
cost. EBITDA in 3Q22 was Bt22,091mn dropped -3.5%YoY mostly from resumed marketing spending and surging network OPEX due to higher utility price and network expansion. It dropped -1.2% QoQ due to core
cost. EBITDA in 3Q22 was Bt22,091mn dropped -3.5%YoY mostly from resumed marketing spending and surging network OPEX due to higher utility price and network expansion. It dropped -1.2% QoQ due to core